Current strategies in the diagnosis of diffuse large B-cell lymphoma of the central nervous system

British Journal of Haematology

Volumn 156, Issue 4, 2012, Pages 421-432

  Baraniskin, Alexander ^a   Deckert, Martina ^b   Schulte Altedorneburg, Gernot ^c   Schlegel, Uwe ^a   Schroers, Roland ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^c Munich Municipal Hospital   (Germany)

Author keywords

Central nervous system lymphoma; Cerebrospinal fluid; Diagnosis; Histopathology; Neuroimaging

Indexed keywords

ANTITHROMBIN; CD27 ANTIGEN; FLUORODEOXYGLUCOSE F 18; GADOLINIUM PENTETATE; IMMUNOGLOBULIN LIGHT CHAIN; MICRORNA;

CENTRAL NERVOUS SYSTEM LYMPHOMA; CENTRAL NERVOUS SYSTEM TUMOR; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; CYTOPATHOLOGY; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DIFFUSION WEIGHTED IMAGING; FLOW CYTOMETRY; GENETIC MARKER; HISTOPATHOLOGY; HUMAN; IMMUNOCOMPROMISED PATIENT; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYMERASE CHAIN REACTION; POSITRON EMISSION TOMOGRAPHY; PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SECONDARY CENTRAL NERVOUS SYSTEM LYMPHOMA; STEREOTACTIC BIOPSY;

BIOLOGICAL MARKERS; BIOPSY; CENTRAL NERVOUS SYSTEM NEOPLASMS; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID PROTEINS; HUMANS; LYMPHOMA, LARGE B-CELL, DIFFUSE; MAGNETIC RESONANCE IMAGING; NEUROIMAGING; PROGNOSIS;

EID: 84856277105     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2011.08928.x     Document Type: Review

References (64)

1. Abrey, L.E., Batchelor, T.T., Ferreri, A.J., Gospodarowicz, M., Pulczynski, E.J., Zucca, E., Smith, J.R., Korfel, A., Soussain, C., Deangelis, L.M., Neuwelt, E.A., O'Neill, B.P., Thiel, E., Shenkier, T., Graus, F., van den, B.M., Seymour, J.F., Poortmans, P., Armitage, J.O. & Cavalli, F. (2005) Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma. Journal of Clinical Oncology, 23, 5034-5043.
2. Abrey, L.E., Ben Porat, L., Panageas, K.S., Yahalom, J., Berkey, B., Curran, W., Schultz, C., Leibel, S., Nelson, D., Mehta, M. & Deangelis, L.M. (2006) Primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center prognostic model. Journal of Clinical Oncology, 24, 5711-5715.
3. Barajas, R.F., Rubenstein, J.L., Chang, J.S., Hwang, J. & Cha, S. (2010) Diffusion-weighted MR imaging derived apparent diffusion coefficient is predictive of cklinical outcome in primary central nervous system lymphoma. AJNR. American Journal of Neuroradiology, 131, 60-66.
4. Baraniskin, A., Kuhnhenn, J., Schlegel, U., Chan, A., Deckert, M., Gold, R., Maghnouj, A., Zollner, H., Reinacher-Schick, A., Schmiegel, W., Hahn, S.A. & Schroers, R. (2011) Identification of microRNAs in the cerebrospinal fluid as marker for primary diffuse large B-cell lymphoma of the central nervous system. Blood, 117, 3140-3146.
5. Bhagavathi, S. & Wilson, J.D. (2008) Primary central nervous system lymphoma. Archives of Pathology & Laboratory Medicine, 132, 1830-1834.
6. Blay, J.Y., Conroy, T., Chevreau, C., Thyss, A., Quesnel, N., Eghbali, H., Bouabdallah, R., Coiffier, B., Wagner, J.P., Le Mevel, A., Dramais-Marcel, D., Baumelou, E., Chauvin, F. & Biron, P. (1998) High-dose methotrexate for the treatment of primary cerebral lymphomas: analysis of survival and late neurologic toxicity in a retrospective series. Journal of Clinical Oncology, 16, 864-871.
7. Buhring, U., Herrlinger, U., Krings, T., Thiex, R., Weller, M. & Kuker, W. (2001) MRI features of primary central nervous system lymphomas at presentation. Neurology, 57, 393-396.
8. Calli, C., Kitis, O., Yunten, N., Yurteseven, T., Islekel, S. & Akalin, T. (2006) Perfusion and diffusion MR imaging in enhancing malignant cerebral tumors. European Journal of Radiology, 58, 394-403.
9. Canonico, B., Zamai, L., Burattini, S., Barnett, D. & Papa, S. (2004) Evaluation of leukocyte stabilisation in TransFix-treated blood samples by flow cytometry and transmission electron microscopy. Journal of Immunological Methods, 295, 67-78.
10. Cinque, P., Brytting, M., Vago, L., Castagna, A., Parravicini, C., Zanchetta, N., D'Arminio, M.A., Wahren, B., Lazzarin, A. & Linde, A. (1993) Epstein-Barr virus DNA in cerebrospinal fluid from patients with AIDS-related primary lymphoma of the central nervous system. Lancet, 342, 398-401.
11. Ciricillo, S.F. & Rosenblum, M.L. (1990) Use of CT and MR imaging to distinguish intracranial lesions and to define the need for biopsy in AIDS patients. Journal of Neurosurgery, 73, 720-724.
12. Cogswell, J.P., Ward, J., Taylor, I.A., Waters, M., Shi, Y., Cannon, B., Kelnar, K., Kemppainen, J., Brown, D., Chen, C., Prinjha, R.K., Richardson, J.C., Saunders, A.M., Roses, A.D. & Richards, C.A. (2008) Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways. Journal of Alzheimer's Disease, 14, 27-41.
13. Corcoran, C., Rebe, K., van der, P.H., Myer, L. & Hardie, D.R. (2008) The predictive value of cerebrospinal fluid Epstein-Barr viral load as a marker of primary central nervous system lymphoma in HIV-infected persons. Journal of Clinical Virology, 42, 433-436.
14. Croce, C.M. (2009) Causes and consequences of microRNA dysregulation in cancer. Nature Reviews. Genetics, 10, 704-714.
15. Deckert, M.A. (2011) Modern concepts in the biology, diagnosis, differential diagnosis and treatment of primary central nervous system lymphoma. Leukemia, doi: [Epub ahead of print].
16. Deckert, M. & Paulus, W. (2007) Malignant lymphomas. In: WHO Classification of Tumours of the Central Nervous System (Eds by D.N. Louis, H. Ohgaki, O.D. Wiestler & W.K. Cavenee), pp. 188-192. IARC, Lyon, France.
17. Deckert-Schluter, M., Rang, A. & Wiestler, O.D. (1998) Apoptosis and apoptosis-related gene products in primary non-Hodgkin's lymphoma of the central nervous system. Acta Neuropathologica, 96, 157-162.
18. Dethy, S., Goldman, S., Blecic, S., Luxen, A., Levivier, M. & Hildebrand, J. (1994) Carbon-11-methionine and fluorine-18-FDG PET study in brain hematoma. Journal of Nuclear Medicine, 35, 1162-1166.
19. Ferreri, A.J., Blay, J.Y., Reni, M., Pasini, F., Spina, M., Ambrosetti, A., Calderoni, A., Rossi, A., Vavassori, V., Conconi, A., Devizzi, L., Berger, F., Ponzoni, M., Borisch, B., Tinguely, M., Cerati, M., Milani, M., Orvieto, E., Sanchez, J., Chevreau, C., Dell'Oro, S., Zucca, E. & Cavalli, F. (2003) Prognostic scoring system for primary CNS lymphomas: the International Extranodal Lymphoma Study Group experience. Journal of Clinical Oncology, 21, 266-272.
20. Ferreri, A.J., Assanelli, A., Crocchiolo, R. & Ciceri, F. (2009) Central nervous system dissemination in immunocompetent patients with aggressive lymphomas: incidence, risk factors and therapeutic options. Hematological Oncology, 27, 61-70.
21. Finn, W.G., Peterson, L.C., James, C. & Goolsby, C.L. (1998) Enhanced detection of malignant lymphoma in cerebrospinal fluid by multiparameter flow cytometry. American Journal of Clinical Pathology, 110, 341-346.
22. Fischer, L., Martus, P., Weller, M., Klasen, H.A., Rohden, B., Roth, A., Storek, B., Hummel, M., Nagele, T., Thiel, E. & Korfel, A. (2008) Meningeal dissemination in primary CNS lymphoma: prospective evaluation of 282 patients. Neurology, 71, 1102-1108.
23. French, C.A., Dorfman, D.M., Shaheen, G. & Cibas, E.S. (2000) Diagnosing lymphoproliferative disorders involving the cerebrospinal fluid: increased sensitivity using flow cytometric analysis. Diagnostic Cytopathology, 23, 369-374.
24. Gleissner, B., Siehl, J., Korfel, A., Reinhardt, R. & Thiel, E. (2002) CSF evaluation in primary CNS lymphoma patients by PCR of the CDR III IgH genes. Neurology, 58, 390-396.
25. Grimm, S.A., McCannel, C.A., Omuro, A.M., Ferreri, A.J., Blay, J.Y., Neuwelt, E.A., Batchelor, T., Jahnke, K., Herrlinger, U., Rubenstein, J., Thiel, E., Doolittle, N., Iwamoto, F.M. & Abrey, L.E. (2008) Primary CNS lymphoma with intraocular involvement: International PCNSL Collaborative Group Report. Neurology, 71, 1355-1360.
26. Haldorsen, I.S., Espeland, A., Larsen, J.L. & Mella, O. (2005) Diagnostic delay in primary central nervous system lymphoma. Acta Oncologica, 44, 728-734.
27. Haldorsen, I.S., Krakenes, J., Krossnes, B.K., Mella, O. & Espeland, A. (2009) CT and MR imaging features of primary central nervous system lymphoma in Norway, 1989-2003. AJNR. American Journal of Neuroradiology, 30, 744-751.
28. Hegde, U., Filie, A., Little, R.F., Janik, J.E., Grant, N., Steinberg, S.M., Dunleavy, K., Jaffe, E.S., Abati, A., Stetler-Stevenson, M. & Wilson, W.H. (2005) High incidence of occult leptomeningeal disease detected by flow cytometry in newly diagnosed aggressive B-cell lymphomas at risk for central nervous system involvement: the role of flow cytometry versus cytology. Blood, 105, 496-502.
29. Hildebrandt, B., Muller, C., Pezzutto, A., Daniel, P., Dorken, B. & Scholz, C. (2007) Assessment of free light chains in the cerebrospinal fluid of patients with lymphomatous meningitis - a pilot study. BMC Cancer, 7, 185.
30. Hintzen, R.Q., van Lier, R.A., Kuijpers, K.C., Baars, P.A., Schaasberg, W., Lucas, C.J. & Polman, C.H. (1991) Elevated levels of a soluble form of the T cell activation antigen CD27 in cerebrospinal fluid of multiple sclerosis patients. Journal of Neuroimmunology, 35, 211-217.
31. Ivers, L.C., Kim, A.Y. & Sax, P.E. (2004) Predictive value of polymerase chain reaction of cerebrospinal fluid for detection of Epstein-Barr virus to establish the diagnosis of HIV-related primary central nervous system lymphoma. Clinical Infectious Disease, 38, 1629-1632.
32. Jahnke, K., Korfel, A., Komm, J., Bechrakis, N.E., Stein, H., Thiel, E. & Coupland, S.E. (2006a) Intraocular lymphoma 2000-2005: results of a retrospective multicentre trial. Graefe's Archieve for Clinical and Experimental Ophthalmology, 244, 663-669.
33. Jahnke, K., Thiel, E., Martus, P., Schwartz, S. & Korfel, A. (2006b) Retrospective study of prognostic factors in non-Hodgkin lymphoma secondarily involving the central nervous system. Annals of Hematology, 85, 45-50.
34. Javedan, S.P. & Tamargo, R.J. (1997) Diagnostic yield of brain biopsy in neurodegenerative disorders. Neurosurgery, 41, 823-828.
35. Johnson, B.A., Fram, E.K., Johnson, P.C. & Jacobowitz, R. (1997) The variable MR appearance of primary lymphoma of the central nervous system: comparison with histopathologic features. AJNR. American Journal of Neuroradiology, 18, 563-572.
36. Josephson, S.A., Papanastassiou, A.M., Berger, M.S., Barbaro, N.M., McDermott, M.W., Hilton, J.F., Miller, B.L. & Geschwind, M.D. (2007) The diagnostic utility of brain biopsy procedures in patients with rapidly deteriorating neurological conditions or dementia. Journal of Neurosurgery, 106, 72-75.
37. Juergens, A., Pels, H., Rogowski, S., Fliessbach, K., Glasmacher, A., Engert, A., Reiser, M., Diehl, V., Vogt-Schaden, M., Egerer, G., Schackert, G., Reichmann, H., Kroschinsky, F., Bode, U., Herrlinger, U., Linnebank, M., Deckert, M., Fimmers, R., Schmidt-Wolf, I.G. & Schlegel, U. (2010) Long-term survival with favorable cognitive outcome after chemotherapy in primary central nervous system lymphoma. Annals of Neurology, 67, 182-189.
38. Kawai, N., Okubo, S., Miyake, K., Maeda, Y., Yamamoto, Y., Nishiyama, Y. & Tamiya, T. (2010) Use of PET in the diagnosis of primary CNS lymphoma in patients with atypical MR findings. Annals of Nuclear Medicine, 24, 335-343.
39. Kersten, M.J., Evers, L.M., Dellemijn, P.L., van den, B.H., Portegies, P., Hintzen, R.Q., van Lier, R.A., dem Borne, A.E. & van Oers, R.H. (1996) Elevation of cerebrospinal fluid soluble CD27 levels in patients with meningeal localization of lymphoid malignancies. Blood, 87, 1985-1989.
40. Kiewe, P., Fischer, L., Martus, P., Thiel, E. & Korfel, A. (2010) Meningeal dissemination in primary CNS lymphoma: diagnosis, treatment, and survival in a large monocenter cohort. Neuro-Oncology, 12, 409-417.
41. Kluin, P.M., Deckert, M. & Ferry, J.A. (2008) Primary diffuse large B-cell lymphoma of the CNS. In: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (ed. by S.H. Swerdlow, E. Campo, N.L. Harris, E.S. Jaffe, S. Pileri, H. Stein, J. Thiele & J.W. Vardiman), pp. 240-241. WHO, Lyon.
42. Kosaka, N., Tsuchida, T., Uematsu, H., Kimura, H., Okazawa, H. & Itoh, H. (2008) 18F-FDG PET of common enhancing malignant brain tumors. AJR. American Journal of Roentgenology, 190, W365-W369.
43. Kuker, W., Nagele, T., Korfel, A., Heckl, S., Thiel, E., Bamberg, M., Weller, M. & Herrlinger, U. (2005) Primary central nervous system lymphomas (PCNSL): MRI features at presentation in 100 patients. Journal of Neuro-Oncology, 72, 169-177.
44. Lawrie, C.H. (2007) MicroRNAs and haematology: small molecules, big function. British Journal of Haematology, 137, 503-512.
45. Montesinos-Rongen, M., Kuppers, R., Schluter, D., Spieker, T., Van Roost, D., Schaller, C., Reifenberger, G., Wiestler, O.D. & Deckert-Schluter, M. (1999) Primary central nervous system lymphomas are derived from germinal-center B cells and show a preferential usage of the V4-34 gene segment. American Journal of Pathology, 155, 2077-2086.
46. Montesinos-Rongen, M., Brunn, A., Bentink, S., Basso, K., Lim, W.K., Klapper, W., Schaller, C., Reifenberger, G., Rubenstein, J., Wiestler, O.D., Spang, R., Dalla-Favera, R., Siebert, R. & Deckert, M. (2008) Gene expression profiling suggests primary central nervous system lymphomas to be derived from a late germinal center B cell. Leukemia, 22, 400-405.
47. Murase, S., Saio, M., Takenaka, K., Shinoda, J., Nishimura, Y., Sakai, N. & Takami, T. (1998) Increased levels of CSF soluble CD27 in patients with primary central nervous system lymphoma. Cancer Letters, 132, 181-186.
48. Murase, S., Saio, M., Andoh, H., Takenaka, K., Shinoda, J., Nishimura, Y., Sakai, N. & Takami, T. (2000) Diagnostic utility of CSF soluble CD27 for primary central nervous system lymphoma in immunocompetent patients. Neurological Research, 22, 434-442.
49. Ney, D.E. & Deangelis, L.M. (2010) Management of central nervous system lymphoma. In: Non-Hodgkin Lymphomas (ed. by J.O. Armitage, P.M. Mauch, N.L. Harris, B. Coiffier & R. Dalla Favera), pp. 527-539. Lippincott Willilams & Wilkins, Philadelphia.
50. Onda, K., Wakabayashi, K., Tanaka, R. & Takahashi, H. (1999) Intracranial malignant lymphomas: clinicopathological study of 26 autopsy cases. Brain Tumor Pathology, 16, 29-35.
51. Palmedo, H., Urbach, H., Bender, H., Schlegel, U., Schmidt-Wolf, I.G., Matthies, A., Linnebank, M., Joe, A., Bucerius, J., Biersack, H.J. & Pels, H. (2006) FDG-PET in immunocompetent patients with primary central nervous system lymphoma: correlation with MRI and clinical follow-up. European Journal of Nuclear Medicine and Molecular Imaging, 33, 164-168.
52. Plowman, P.N., Saunders, C.A. & Maisey, M.N. (1998) Gliomatosis cerebri: disconnection of the cortical grey matter, demonstrated on PET scan. British Journal of Neurosurgery, 12, 240-244.
53. Quijano, S., Lopez, A., Manuel, S.J., Panizo, C., Deben, G., Castilla, C., Antonio Garcia-Vela, J., Salar, A., Alonso-Vence, N., Gonzalez-Barca, E., Penalver, F.J., Plaza-Villa, J., Morado, M., Garcia-Marco, J., Arias, J., Briones, J., Ferrer, S., Capote, J., Nicolas, C. & Orfao, A. (2009) Identification of leptomeningeal disease in aggressive B-cell non-Hodgkin's lymphoma: improved sensitivity of flow cytometry. Journal of Clinical Oncology, 27, 1462-1469.
54. Roy, S., Josephson, S.A., Fridlyand, J., Karch, J., Kadoch, C., Karrim, J., Damon, L., Treseler, P., Kunwar, S., Shuman, M.A., Jones, T., Becker, C.H., Schulman, H. & Rubenstein, J.L. (2008) Protein biomarker identification in the CSF of patients with CNS lymphoma. Journal of Clinical Oncology, 26, 96-105.
55. Schabet, M. (1999) Epidemiology of primary CNS lymphoma. Journal of Neuro-Oncology, 43, 199-201.
56. Schlegel, U. (2009) Primary CNS lymphoma. Therapeutic Advances in Neurological Disorders, 2, 93-104.
57. Schramm, P., Xyda, A., Klotz, E., Tronnier, V., Knauth, M. & Hartmann, M. (2010) Dynamic CT perfusion imaging of intra-axial brain tumors: differentiation of high-grade gliomas from primary CNS lymphomas. European Radiology, 20, 2482-2490.
58. Schroers, R., Baraniskin, A., Heute, C., Vorgerd, M., Brunn, A., Kuhnhenn, J., Kowoll, A., Alekseyev, A., Schmiegel, W., Schlegel, U., Deckert, M. & Pels, H. (2010a) Diagnosis of leptomeningeal disease in diffuse large B-cell lymphomas of the central nervous system by flow cytometry and cytopathology. European Journal of Haematology, 85, 520-528.
59. Schroers, R., Baraniskin, A., Heute, C., Kuhnhenn, J., Alekseyev, A., Schmiegel, W., Schlegel, U. & Pels, H.J. (2010b) Detection of free immunoglobulin light chains in cerebrospinal fluids of patients with central nervous system lymphomas. European Journal of Haematology, 85, 236-242.
60. Schulte-Altedorneburg, G., Heuser, L. & Pels, H. (2011) MRI patterns in recurrence of primary CNS lymphoma in immunocompetent patients. European Journal of Radiology, doi: [Epub ahead of print].
61. Shenkier, T.N., Blay, J.Y., O'Neill, B.P., Poortmans, P., Thiel, E., Jahnke, K., Abrey, L.E., Neuwelt, E., Tsang, R., Batchelor, T., Harris, N., Ferreri, A.J., Ponzoni, M., O'Brien, P., Rubenstein, J. & Connors, J.M. (2005) Primary CNS lymphoma of T-cell origin: a descriptive analysis from the international primary CNS lymphoma collaborative group. Journal of Clinical Oncology, 23, 2233-2239.
62. Thompsett, A.R., Ellison, D.W., Stevenson, F.K. & Zhu, D. (1999) V(H) gene sequences from primary central nervous system lymphomas indicate derivation from highly mutated germinal center B cells with ongoing mutational activity. Blood, 94, 1738-1746.
63. Tsuyuguchi, N., Sunada, I., Ohata, K., Takami, T., Nishio, A., Hara, M., Kawabe, J., Okamura, T. & Ochi, H. (2003) Evaluation of treatment effects in brain abscess with positron emission tomography: comparison of fluorine-18-fluorodeoxyglucose and carbon-11-methionine. Annals of Nuclear Medicine, 17, 47-51.
64. Zacharia, T.T., Law, M., Naidich, T.P. & Leeds, L.E. (2008) Central nervous sytem lymphoma characterization by diffusion-weighted imagingand MR spectroscopy. Journal of Neuroimaging, 18, 411-417.